Previous studies also show that NR4A1 and other nuclear receptors can act as nuclear cofactors that interact with DNA bound Sp1 to regulate basal gene expression in cancer cells and receptor ligands such as DIM-3,5 compounds can modulate (inhibit or induce) expression of the Sp-regulated genes through a cofactor-dependent pathway [38]. The gene discussed is TFF2; the disease is cancer.